The Shorts Are Wrong About This Stock

The following video is part of our "Motley Fool Conversations" series, in which analyst John Reeves and advisor David Meier discuss topics across the investing world.

David and John talk about MAKO Surgical, a company they believe is misunderstood by short-sellers. David does concede that short-sellers are smart investors who do their homework. But in this case, he believes they don't appreciate the long-term trends that will benefit MAKO Surgical over time.

Health-care investors are always looking for the next big breakthrough. Motley Fool co-founder David Gardner recently identified a small-cap health-care company that he believes is poised for monster returns. To uncover this top pick today, enjoy our special free report: "Discover the Next Rule-Breaking Multibagger." Don't miss out on this limited-time offer and your opportunity to discover this game-changing company before the market does. Click here to access your report -- it's totally free.

David Meier and John Reeves have no positions in the stocks mentioned above. The Motley Fool owns shares of GameStop, Intuitive Surgical, and MAKO Surgical. Motley Fool newsletter services recommend hhgregg, Intuitive Surgical, and MAKO Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (2) | Recommend This Article (14)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 18, 2012, at 1:10 AM, strelna wrote:

    Surely the interesting point is the one fact advanced (aging demographic and obesity = joint replacement) in relation to price. To talk about the first and not the second is superficial. I never tire of asking RB-type TMF stock proponents (who are often, even usually right) a legitimate question they hate and fear (it is never, and I repeat never, answered): what would you not pay for (MAKO, AMZN, NFLX, LULU, CMG etc. etc.?) Interesting eh? I know you would not pay anything unless you are mad. So: valuation parameters please. At what level of what ratio would MAKO be unattractive?

  • Report this Comment On April 18, 2012, at 1:15 AM, strelna wrote:

    PS:

    In this situation, divide PS by something positive.

    I have a holding in MAKO.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1862873, ~/Articles/ArticleHandler.aspx, 10/31/2014 9:40:13 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement